[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100652663":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":25,"centralContacts":30,"locations":25,"responsibleParty":36,"collaborators":25,"id":38,"slug":39,"hasResults":40,"nctId":41,"briefTitle":42,"officialTitle":43,"acronym":25,"eligibilityCriteria":44,"healthyVolunteers":40,"sex":45,"minAge":46,"maxAge":47,"enrollmentInfo":48,"targetDuration":25,"studyType":51,"phases":52,"briefSummary":54,"conditions":55,"keywords":58,"overallStatus":63,"whyStopped":25,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":68,"completionDateStruct":70,"leadSponsor":72,"locationsCount":25},{"fullName":5,"class":6},"EPC Education s.r.o.","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Group 1","EXPERIMENTAL","4 mL of 1% lidocaine followed by 12 mL of sodium hyaluronate",[13],"Other: Sodium Hyaluronate Injection",{"label":15,"type":16,"description":17,"interventionNames":18},"Group 2","ACTIVE_COMPARATOR","4 mL of 1% lidocaine followed by 12 mL of normal saline",[19],"Other: Saline Injections",[21,26],{"type":6,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"Sodium Hyaluronate Injection","Sodium hyaluronate injections added to standard lidocaine injection.",[9],null,{"type":6,"name":27,"description":28,"armGroupLabels":29,"otherNames":25},"Saline Injections","Normal saline added to standard lidocaine injection, which reflects current clinical practice.",[15],[31],{"name":32,"role":33,"phone":34,"phoneExt":25,"email":35},"Michal Matias, MD, FIPP","CONTACT","+420602246127","matias@europainclinics.com",{"type":37,"investigatorFullName":25,"investigatorTitle":25,"investigatorAffiliation":25,"oldNameTitle":25,"oldOrganization":25},"SPONSOR","100652663","sodium-hyaluronate-for-myofascial-thoracic-pain-100652663",false,"NCT07775274","Sodium Hyaluronate for Myofascial Thoracic Pain","Sodium Hyaluronate for Myofascial Thoracic Pain: A Randomized Double-blind Controlled Trial","Inclusion Criteria:\n\n* Thoracic back pain as the primary complaint\n* Clinically significant myofascial contribution, defined by at least two of the following:\n\n  * Localized tenderness\n  * Paravertebral muscle spasm\n  * Trigger points\n  * Reduced skin or fascial mobility\n* Persistent pain despite at least 6 weeks of conservative treatment\n* Absence of more specific causes of pain, as determined by clinical examination and additional investigations when indicated\n* Age over 18 years\n\nConditions to be excluded prior to enrollment include:\n\n* Neuropathic pain patterns, including:\n\n  * Cervical or thoracic radicular pain\n  * Intercostal neuralgia\n  * Dorsal scapular neuralgia\n  * Other neuralgias of thoracic region\n* Pleural pain patterns\n* Ischemic pain patterns (e.g., ischemic heart disease)\n* Predominantly postural pain associated with female sex and osteopenia suggestive of vertebral compression fractures\n\nExclusion Criteria:\n\n* Lack of written informed consent\n* Active malignancy\n* Recent trauma\n* Age \\> 70 years\n* Local or systemic infection\n* Presence of another more likely pain etiology\n* Severe scoliosis and\u002For significant chest wall deformity\n* History of thoracic or upper abdominal surgery\n* History of spinal surgery of any kind","ALL","18 Years","70 Years",{"count":49,"type":50},100,"ESTIMATED","INTERVENTIONAL",[53],"NA","To determine whether the addition of sodium hyaluronate to standard ultrasoundguided lidocaine injection provides superior and sustained pain relief compared with standard lidocaine injection alone in patients with suspected myofascial or nonspecific thoracic back pain.",[56,57],"Thoracic Pain","Back Pain",[59,60,61,62],"myofascial complex","sodium hyaluronate","ultrasound-guided","thoracic back pain","NOT_YET_RECRUITING","2026-08-19",{"date":66,"type":67},"2026-08-20","ACTUAL",{"date":69,"type":50},"2026-08-31",{"date":71,"type":50},"2029-02-20",{"name":5,"class":6}]